Intellia Therapeutics NTLA
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$8.57M (7 inflow days, 13 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 38.2% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 32.03% to 31.66% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Federated Hermes, Inc. | Mutual Fund | 2026/Q3 | +850,265 | 1.1% |
| Amova Asset Management | Mutual Fund | 2026/Q3 | +708,094 | 2.6% |
| Sumitomo Mitsui Trust Asset Management | Mutual Fund | 2026/Q3 | +708,094 | 2.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +626,400 | 11.4% |
| Connor, Clark & Lunn Investment Management Ltd. | Mutual Fund | 2026/Q3 | +486,067 | 1.0% |
| Contrarius Investment Management Ltd. | Mutual Fund | 2026/Q3 | +476,991 | 1.7% |
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +374,356 | 0.5% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +357,651 | 0.3% |
| RA Capital Management, L.P. | VC/PE Fund | 2026/Q3 | +4,526,926 | 3.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +3,253,217 | 11.0% |
| FMR | Mutual Fund | 2026/Q3 | +2,705,884 | 3.4% |
| ARK Investment Management LLC | Mutual Fund | 2026/Q3 | +2,366,437 | 12.0% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +2,312,311 | 6.6% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +1,883,517 | 2.3% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +1,400,004 | 1.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 1 Nov 2026 | John Leonard | Chief Executive Officer | Automatic Disposition | -9,000 | $11.99 | 1,196,479 |
| 25 Oct 2026 | Jing Marantz | EVP & Chief Medical Officer | Other Acquisition | +199,822 | – | 199,822 |
| 25 Oct 2026 | Jing Marantz | EVP & Chief Medical Officer | Other Derivative Acquisition | +275,061 | $11.26 | 275,061 |
| 1 Oct 2026 | Michael Dube | Vice President | Open Market Disposition | -1,864 | $12.43 | 65,022 |
| 20 Aug 2026 | John Leonard | Chief Executive Officer | Automatic Disposition | -22,675 | $13.00 | 1,205,479 |
| 19 Aug 2026 | John Leonard | Chief Executive Officer | Intent to Sell (Form 144) | -22,675 | $12.95 | – |
| 21 Jul 2026 | Edward Dulac | Chief Financial Officer | Open Market Disposition | -8,111 | $11.25 | 148,175 |
| 1 Jul 2026 | Edward Dulac | Chief Financial Officer | Automatic Disposition | -4,677 | $18.00 | 156,286 |
| 30 Jun 2026 | Michael Dube | Vice President | Open Market Disposition | -2,641 | $16.78 | 66,886 |
| 8 Jun 2026 | Fred Cohen | Independent Director | Other Acquisition | +9,200 | – | 17,200 |
| 8 Jun 2026 | Fred Cohen | Independent Director | Other Derivative Acquisition | +13,300 | $12.89 | 13,300 |
| 8 Jun 2026 | Franciscus A. G. Verwiel | Independent Chairperson | Other Acquisition | +9,200 | – | 17,200 |
| 8 Jun 2026 | Franciscus A. G. Verwiel | Independent Chairperson | Other Derivative Acquisition | +13,300 | $12.89 | 13,300 |
| 8 Jun 2026 | William Chase | Independent Director | Other Acquisition | +9,200 | – | 143,893 |
| 8 Jun 2026 | William Chase | Independent Director | Other Derivative Acquisition | +13,300 | $12.89 | 13,300 |
| 8 Jun 2026 | Brian Goff | Independent Director | Other Acquisition | +9,200 | – | 17,200 |
| 8 Jun 2026 | Brian Goff | Independent Director | Other Derivative Acquisition | +13,300 | $12.89 | 13,300 |
| 8 Jun 2026 | Jesse Goodman | Independent Director | Other Acquisition | +9,200 | – | 17,200 |
| 8 Jun 2026 | Jesse Goodman | Independent Director | Other Derivative Acquisition | +13,300 | $12.89 | 13,300 |
| 8 Jun 2026 | Georgia Keresty | Independent Director | Other Acquisition | +9,200 | – | 17,200 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 44,361,762 | 31.7% | 11.1 |
| 15 Oct 2026 | 44,435,219 | 31.7% | 6.5 |
| 30 Sep 2026 | 45,110,513 | 32.2% | 9.5 |
| 15 Sep 2026 | 46,681,609 | 33.3% | 14.1 |
| 31 Aug 2026 | 43,928,014 | 31.3% | 12.9 |
| 14 Aug 2026 | 44,880,339 | 32.0% | 13.2 |
No comments yet — be the first to weigh in on NTLA.
Sign in to join the discussion.